AcceleratorHack40 is a global operating partner that drives innovation and supports international growth for startups and companies through structured programs. They specialize in corporate innovation and startup acceleration.
Loading

The Health&BioTech Accelerator is an international corporate scale-up program based in Milan, Italy, focused on selecting promising health and biotech startups and scale-ups that align with corporate partners' innovation needs.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
The Health&BioTech Accelerator is an international corporate scale-up program based in Milan, Italy. It focuses on selecting promising health and biotech start-ups and scale-ups that align with the innovation needs of corporate partners. The program aims to foster strong business partnerships through the design and execution of joint pilot projects.
The Health&BioTech Accelerator invests in various sectors within healthcare and biotechnology, including Drug Discovery & Development, AI Drug Design, Data Analytics & Big Data, New Drugs & Therapies, Biologics and Cell and Gene Therapies, Diagnostics and Genetic Testing, Digital Health Solutions, and Telemedicine and Remote Patient Monitoring. The program supports start-ups at various stages, facilitating partnerships with market-leading corporates across the healthcare and biotech value chain.
Founders benefit from access to corporate partners, opportunities for pilot projects, and support in navigating the healthcare and biotech landscape.
<p><strong>What are the eligibility criteria for the Health&BioTech Accelerator?</strong></p><p>The accelerator focuses on health and biotech start-ups and scale-ups at various stages, including pre-seed, seed, and seed+. Start-ups should align with the innovation needs of corporate partners.</p><p><strong>How does the application process work?</strong></p><p>Interested start-ups can apply through the Health&BioTech Accelerator's website. Specific deadlines and requirements are typically outlined during the application period.</p><p><strong>What are the deal terms offered by the accelerator?</strong></p><p>Details regarding investment amounts and equity stakes are not specified. However, the accelerator provides access to corporate partners and opportunities for pilot projects.</p><p><strong>What is the format of the program?</strong></p><p>The program operates on a global scale, supporting start-ups through various stages of development. The structure emphasizes collaboration with corporate partners.</p><p><strong>What makes the Health&BioTech Accelerator different from others?</strong></p><p>The accelerator's focus on aligning start-ups with corporate innovation needs and facilitating pilot projects sets it apart. This approach enhances the potential for successful business partnerships.</p><p><strong>What success metrics does the accelerator track?</strong></p><p>The Health&BioTech Accelerator tracks the number of start-ups engaged, pilot projects facilitated, and business agreements achieved as key indicators of success.</p>
Superscout Pro

Superscout documents Health&BioTech Accelerator independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.